Gilead Sciences, 333 Lakeside Drive, Foster City, CA, USA.
Genentech, Inc., 1 DNA Way, South San Francisco, CA, 94080, USA.
Regul Toxicol Pharmacol. 2021 Mar;120:104843. doi: 10.1016/j.yrtph.2020.104843. Epub 2020 Dec 17.
This study assesses whether currently available acute oral toxicity (AOT) in silico models, provided by the widely employed Leadscope software, are fit-for-purpose for categorization and labelling of chemicals. As part of this study, a large data set of proprietary and marketed compounds from multiple companies (pharmaceutical, plant protection products, and other chemical industries) was assembled to assess the models' performance. The absolute percentage of correct or more conservative predictions, based on a comparison of experimental and predicted GHS categories, was approximately 95%, after excluding a small percentage of inconclusive (indeterminate or out of domain) predictions. Since the frequency distribution across the experimental categories is skewed towards low toxicity chemicals, a balanced assessment was also performed. Across all compounds which could be assigned to a well-defined experimental category, the average percentage of correct or more conservative predictions was around 80%. These results indicate the potential for reliable and broad application of these models across different industrial sectors. This manuscript describes the evaluation of these models, highlights the importance of an expert review, and provides guidance on the use of AOT models to fulfill testing requirements, GHS classification/labelling, and transportation needs.
本研究评估了目前广泛使用的 Leadscope 软件提供的急性口服毒性(AOT)计算模型是否适用于化学品的分类和标签。作为本研究的一部分,我们汇集了来自多家公司(制药、植保产品和其他化学工业)的专有和市售化合物的大型数据集,以评估这些模型的性能。在排除少量不确定(不确定或不在范围内)预测后,基于实验和预测的 GHS 类别比较,正确或更保守预测的绝对百分比约为 95%。由于实验类别中的频率分布偏向于低毒性化学品,因此还进行了平衡评估。对于可以明确分配到实验类别中的所有化合物,正确或更保守预测的平均百分比约为 80%。这些结果表明,这些模型在不同工业部门具有可靠和广泛应用的潜力。本文描述了这些模型的评估,强调了专家审查的重要性,并提供了使用 AOT 模型满足测试要求、GHS 分类/标签和运输需求的指导。